Catharien M Hilkens
Overview
Explore the profile of Catharien M Hilkens including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
536
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schittenhelm L, Robertson J, Pratt A, Hilkens C, Morrison V
Rheumatology (Oxford)
. 2020 Oct;
60(3):1533-1542.
PMID: 33123735
Objectives: Immune dysregulation contributes to the development of RA. Altered surface expression patterns of integrin adhesion receptors by immune cells is one mechanism by which this may occur. We investigated...
2.
Schittenhelm L, Hilkens C, Morrison V
Front Immunol
. 2018 Jan;
8:1866.
PMID: 29326724
Emerging evidence suggests that the β integrin family of adhesion molecules have an important role in suppressing immune activation and inflammation. β integrins are important adhesion and signaling molecules that...
3.
Cowell J, Buck M, Essa A, Clarke R, Vollmer W, Vollmer D, et al.
Chembiochem
. 2017 Jun;
18(17):1688-1691.
PMID: 28581639
Biotinylation of amines is widely used to conjugate biomolecules, but either the resulting label is non-removable or its removal leaves a tag on the molecule of interest, thus affecting downstream...
4.
Garcia-Gonzalez P, Schinnerling K, Sepulveda-Gutierrez A, Maggi J, Hoyos L, Morales R, et al.
Front Immunol
. 2016 Nov;
7:458.
PMID: 27826300
Tolerogenic dendritic cells (TolDCs) are promising tools for therapy of autoimmune diseases, such as rheumatoid arthritis (RA). Here, we characterize monocyte-derived TolDCs from RA patients modulated with dexamethasone and activated...
5.
Maggi J, Schinnerling K, Pesce B, Hilkens C, Catalan D, Aguillon J
Front Immunol
. 2016 Oct;
7:359.
PMID: 27698654
Tolerogenic dendritic cells (DCs) are a promising tool to control T cell-mediated autoimmunity. Here, we evaluate the ability of dexamethasone-modulated and monophosphoryl lipid A (MPLA)-activated DCs [MPLA-tolerogenic DCs (tDCs)] to...
6.
Collerton J, Martin-Ruiz C, Davies K, Hilkens C, Isaacs J, Kolenda C, et al.
Mech Ageing Dev
. 2012 Jun;
133(6):456-66.
PMID: 22663935
Age-related frailty is an increasing societal challenge with growing emphasis on identifying its underlying pathophysiology and prospects for intervention. We report findings from the first comprehensive study of frailty and...
7.
Mailliard R, Wankowicz-Kalinska A, Cai Q, Wesa A, Hilkens C, Kapsenberg M, et al.
Cancer Res
. 2004 Sep;
64(17):5934-7.
PMID: 15342370
Using the principle of functional polarization of dendritic cells (DCs), we have developed a novel protocol to generate human DCs combining the three features critical for the induction of type-1...